Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 6,050 shares at $131.02 ($789K) on 2026-08-06, disclosed to the SEC on 2026-08-10.
Open-market sale of $789k MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.23 | 4,945 | $644K | 81.6% |
| 2 | $131.02 | 805 | $105K | 13.4% |
| 3 | $131.02 | 300 | $39K | 5.0% |
| Total | $130.38 avg | 6,050 | $789K | 100% |
| Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |
| MRK | SELL | 2022-11-01 | $33.0M | — | Filing → |